Insights on Alzheimer's offers clues for new drugs

Gene mutations in the A beta protein are assisting these proteins in clumping together, which in turn is promoting Alzheimer's, according to a scientific team at UCLA. The researchers say that a new drug that can block the formation of A beta and prevent it from sticking together in clumps could prevent the disease from ever occurring. And their work may help developers take the right approach. The principal investigator is David Teplow, professor of neurology at the David Geffen School of Medicine at UCLA. The Proceedings of the National Academy of Sciences published the findings in its Oct. 10 online early edition.

- check out the release for more information

Suggested Articles

Compass' CD137 agonist cleared large tumors in mice that other I-O agents had failed to treat. It's advancing the drug into phase 1 human trials.

UPMC researchers are planning clinical trials of a COVID-19 vaccine that uses pieces of the virus' spike protein to create immunity.

Treating mice with niacin increased the number of immune cells in glioblastomas, reducing tumor size and extending survival.